Seventy-one (44.7%) cases were diagnosed as an oligodendroglioma, IDH-mutant, and 1p/19q codeleted, and 88 (55.3%) as astrocytoma, IDH-mutant. This evidence concerns the gene IDH2 and oligodendroglioma.